[1]

Kidd M, Modlin IM, Drozdov I, et al. A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis[J/OL]. Oncotarget, 2018, 9(6): 7182−7196[2019-01-28]. https://www.ncbi.nlm.nih.gov/pubmed/29467960. DOI: 10.18632/oncotarget.23820.
[2] Rossi G, Bertero L, Marchiò C, et al.  Molecular alterations of neuroendocrine tumours of the lung[J]. Histopathology, 2018, 72(1): 142-152.   doi: 10.1111/his.13394
[3] 谭月发, 许乙凯, 余田, 等.  多层螺旋CT对肺类癌的诊断及鉴别诊断[J]. 放射学实践, 2011, 26(8): 832-835.   doi: 10.3969/j.issn.1000-0313.2011.08.009
Tan YF, Xu YK, Yu T, et al.  Diagnosis and differential diagnosis of pulmonary carcinoid with multi-slice computed tomography[J]. Radiol Pract, 2011, 26(8): 832-835.   doi: 10.3969/j.issn.1000-0313.2011.08.009
[4] 林吉征, 张亮, 王军伟, 等.  肺类癌的多层螺旋CT表现[J]. 实用放射学杂志, 2013, 29(1): 25-27.   doi: 10.3969/j.issn.1002-1671.2013.01.007
Lin JZ, Zhang L, Wang JW, et al.  MSCT features of pulmonary carcinoid tumors[J]. J Pract Radiol, 2013, 29(1): 25-27.   doi: 10.3969/j.issn.1002-1671.2013.01.007
[5] 杨燕, 孟娴, 黄信源, 等.  原发性支气管肺类癌MSCT诊断(附7例报告)[J]. 影像诊断与介入放射学, 2017, 26(5): 388-392.   doi: 10.3969/j.issn.1005-8001.2017.05.007
Yang Y, Meng X, Huang XY, et al.  Multislice helical CT diagnosis of primary bronchial carcinoid: seven case reports[J]. Diagn Imaging Interv Radiol, 2017, 26(5): 388-392.   doi: 10.3969/j.issn.1005-8001.2017.05.007
[6] Prosch H.  Pulmonary carcinoid tumors[J]. Radiologe, 2017, 57(5): 397-406.   doi: 10.1007/s00117-017-0243-x
[7] Cattoni M, Vallières E, Brown LM, et al.  Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?[J]. Eur J Cardiothorac Surg, 2017, 51(5): 874-879.   doi: 10.1093/ejcts/ezw422
[8] 刘广杰, 刘庆熠, 解少男, 等.  原发性肺类癌患者的临床特征和预后研究[J]. 中国全科医学, 2014, 17(1): 34-38.   doi: 10.3969/j.issn.1007-9572.2014.01.012
Liu GJ, Liu QY, Xie SN, et al.  Clinical characteristics and prognostic factors of primary pulmonary carcinoid tumors[J]. Chin Gen Pract, 2014, 17(1): 34-38.   doi: 10.3969/j.issn.1007-9572.2014.01.012
[9]

Stefani A, Franceschetto A, Nesci J, et al. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung[J/OL]. J Cardiothorac Surg, 2013, 8: 223[2019-01-28]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879007. DOI: 10.1186/1749−8090−8−223.
[10] Jindal T, Kumar A, Venkitaraman B, et al.  Evaluation of the role of [18F] FDG-PET/CT and [68Ga] DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids[J]. Cancer Imaging, 2011, 11(1): 70-75.   doi: 10.1102/1470-7330.2011.0010
[11] Lococo F, Perotti G, Cardillo G, et al.  Multicenter Comparison of 18F-FDG and 68Ga-DOTA-Peptide PET/CT for Pulmonary Carcinoid[J]. Clin Nucl Med, 2015, 40(3): e183-e189.   doi: 10.1097/RLU.0000000000000641
[12] 李国雄, 刘志军, 张海捷, 等.  肺硬化性肺泡细胞瘤的18F-FDG PET/CT显像特征[J]. 中国医学影像技术, 2017, 33(6): 889-892.   doi: 10.13929/j.1003-3289.201609089
Li GX, Liu ZJ, Zhang HJ, et al.  18F-FDG PET/CT features of pulmonary sclerosing pneumocytoma[J]. Chin J Med Imaging Technol, 2017, 33(6): 889-892.   doi: 10.13929/j.1003-3289.201609089
[13] Uhlén N, Grundberg O, Jacobsson H, et al.  18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas[J]. Clin Nucl Med, 2016, 41(4): 263-267.   doi: 10.1097/RLU.0000000000001114